Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03764696
Other study ID # CYH002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2021
Est. completion date December 31, 2021

Study information

Verified date August 2023
Source Navy General Hospital, Beijing
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Supplementary oxygen is routinely administered to patients, even those with adequate oxygen saturations, in the belief that it increases oxygen delivery. However, oxygen delivery depends not just on arterial oxygen content but also on perfusion. Maternal oxygen administration has been used in an attempt to lessen fetal distress by increasing the available oxygen from the mother. However, the effect of supplemental maternal oxygen therapy on fetal acid base status has been debated for more than seven decades. The investigators found the use of 2 L/min maternal oxygen during the second stage of labor did not adversely affect either the umbilical artery pH value or the fetal heart rate (FHR) pattern distribution.


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date December 31, 2021
Est. primary completion date October 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: at term (>37 weeks, <42 weeks), singleton, cephalic presentation, spontaneous or induced labor, normal labor, category I FHR tracings, 2 to 3 cm of cervical dilation in nulliparity, 1 to 2 cm of cervical dilation in multipara, informed consent. Exclusion Criteria: respiratory or cardiovascular disease, diabetes mellitus or insulin-treated gestational diabetes mellitus, hypertension or preeclampsia, oligohydramnios, fetal growth restriction, placental abruption, cephalopelvic disproportion, meconium-stained amniotic fluid, tachysystole, having received O2, uterine incision (myomectomy or perforation), anemia, fever, chorioamnionitis, tobacco or alcohol use, disorders in oxygen saturations, hypotension, uncomfortable with facemask.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
tight-fitting simple facemask
Oxygen will be administered by facemask at 10 L/min oxygen. The therapy will continue until after delivery

Locations

Country Name City State
China Department of Obstetrics and Gynecology, PLA Strategic Support Force Characteristic Medical Center Beijing
China Department of Obstetrics and Gynecology, Seventh Medical Center, Chinese PLA General Hospital Beijing
China Department of Obstetrics and Gynecology, Sixth Medical Center, Chinese PLA General Hospital Beijing

Sponsors (1)

Lead Sponsor Collaborator
Navy General Hospital, Beijing

Country where clinical trial is conducted

China, 

References & Publications (2)

Chuai F, Dong T, Liu Y, Jiang W, Zhang L, Chen L, Chuai Y, Zhou Y. The effect of intrapartum prolonged oxygen exposure on fetal metabolic status: secondary analysis from a randomized controlled trial. Front Endocrinol (Lausanne). 2023 Jun 27;14:1204956. doi: 10.3389/fendo.2023.1204956. eCollection 2023. — View Citation

Chuai Y, Jiang W, Zhang L, Chuai F, Sun X, Peng K, Gao J, Dong T, Chen L, Yao Y. Effect of long-duration oxygen vs room air during labor on umbilical cord venous partial pressure of oxygen: a randomized controlled trial. Am J Obstet Gynecol. 2022 Oct;227(4):629.e1-629.e16. doi: 10.1016/j.ajog.2022.05.028. Epub 2022 May 14. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Rate of cesarean delivery at 1 minute after birth
Other Rate of assisted vaginal delivery at 1 minute after birth
Other Apgar score less than 7 The Apgar scale is determined by evaluating the newborn baby on five simple criteria on a scale from 0 to 2, then summing up the five values thus obtained. The resulting Apgar score ranges from 0 to 10. The five criteria are summarized using words chosen (Appearance, Pulse, Grimace, Activity, Respiration). The infant is given a score of 0, 1 or 2. The scores are added up and the total sum is their Apgar score.
The test is generally done at one and five minutes after birth, and may be repeated later if the score is and remains low. Scores 7 and above are generally normal, 4 to 6 fairly low, and 3 and below are generally regarded as critically low.
at 1 and 5 minutes after birth
Other Rate of serious neonatal morbidity or death within 28 days of birth
Other Cord arterial plasma liquid chromatography mass spectrometry analysis The systematic identification and quantitation of all the metabolic products (mainly endogenous small molecule compounds with relative molecular weight within 1000 Da) of cord arterial plasma under oxygen and room air conditions. Immediately after delivery (within 30-60 seconds of birth), blood plasma sample will be obtained. within 30 to 60 seconds of birth
Primary Cord arterial pH values Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. within 30 to 60 seconds of birth
Primary Cord arterial partial pressure of oxygen Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. within 30 to 60 seconds of birth
Primary Cord arterial partial pressure of carbon dioxide Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. within 30 to 60 seconds of birth
Primary Cord venous pH values Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. within 30 to 60 seconds of birth
Primary Cord venous partial pressure of oxygen Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. within 30 to 60 seconds of birth
Primary Cord venous partial pressure of carbon dioxide Immediately after delivery (within 30-60 seconds of birth), blood gas sample will be obtained. within 30 to 60 seconds of birth
Secondary Rate of abnormal fetal heart tracing at 1 minute after birth
See also
  Status Clinical Trial Phase
Completed NCT02221440 - Maternal Oxygen Administration for Fetal Distress N/A
Completed NCT04325243 - Sildenafil Citrate and Intrapartum Fetal Distress Phase 4
Completed NCT03095937 - Evaluation of Fetal Cardiac Function in Rheumatic Heart Disease (RHD) Patients
Completed NCT00185887 - Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation N/A
Completed NCT02862925 - Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings. N/A
Recruiting NCT06186973 - Fetal Assessment of the Myocardium and Evaluation of the Neonate
Recruiting NCT05681624 - Maternal Oxygen Supplementation for Intrauterine Resuscitation N/A
Completed NCT05946681 - Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
Completed NCT03536910 - Evaluation of Copeptin Levels in Elective Cesarean Section With Different Anesthetic Technique N/A
Completed NCT03156608 - Novii External Fetal Monitoring Device N/A
Recruiting NCT00246766 - Study of Fetal Movements Using Multichannel Ultrasound Pulsed Doppler in Normal and Pathologic Pregnancy N/A
Recruiting NCT04043299 - Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes Phase 3
Not yet recruiting NCT03859037 - Effect of Umbilical Cord Milking on Transition of Preterm Babies During Resuscitation N/A
Completed NCT03370822 - A Mixed Methods Study to Explore the Feasibility of a Novel Continuous Fetal Monitoring Device
Terminated NCT05147584 - Trans-abdominal Fetal Pulse Oximetry N/A
Not yet recruiting NCT05727241 - Three-dimensional Umbilical Cord Coiling Index
Terminated NCT04081584 - Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering
Completed NCT01042262 - Maternal Oxygen Use During Delivery and Cord Blood Superoxide Dismutase N/A
Not yet recruiting NCT04548453 - Establish the uSI Values and End-user Training Material That Will be Used to Guide Oxytocin Dosing Actions Early Phase 1
Completed NCT03159234 - Prediction of Fetal Lung Maturity N/A